FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090234 [Registered on: 04/07/2025] Trial Registered Prospectively
Last Modified On: 01/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia
Preventive 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Oral Tablet Midodrine for preventing hypotension after spinal anaesthesia 
Scientific Title of Study   Comparing efficacy of two doses of preoperative oral midodrine for preventing hypotension after spinal anaesthesia during lower limb orthopaedic surgeries A Randomized controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Beepata Avanthika 
Designation  Junior Resident 
Affiliation  AIIMS Gorakhpur 
Address  First Floor OT Complex Hospital Building Department of Anesthesia AIIMS Gorakhpur

Gorakhpur
UTTAR PRADESH
273008
India 
Phone  6309854546  
Fax    
Email  beepataavanthika@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr GANESH RAMAJI NIMJE 
Designation  Associate Professor 
Affiliation  AIIMS Gorakhpur 
Address  Room No 101 First Floor OT Complex Department of Anesthesia AIIMS Gorakhpur

Gorakhpur
UTTAR PRADESH
273008
India 
Phone  9503332784  
Fax    
Email  ganesh.nimje8@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr GANESH RAMAJI NIMJE 
Designation  Associate Professor 
Affiliation  AIIMS Gorakhpur 
Address  Room No 101 First Floor OT Complex AIIMS Gorakhpur
AIIMS Gorakhpur
Gorakhpur
UTTAR PRADESH
273008
India 
Phone  9503332784  
Fax    
Email  ganesh.nimje8@gmail.com  
 
Source of Monetary or Material Support  
AIIMS Gorakhpur Uttar Pradesh 
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [NIL] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR AVANTHIKA BEEPATA  AIIMS Gorakhpur  Department of Anesthesia Orthopedic OT Complex Room No 2
Gorakhpur
UTTAR PRADESH 
6309854546

beepataavanthika@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Human Ethics Committee, AIIMS Gorakhpur, India  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group 1- 5 mg Midodrine  Preoperative oral midodrine 5mg, administered 120 mins with sips of water before spinal anesthesia 
Intervention  Group 2- 10 mg Midodrine  Preoperative oral midodrine 10mg, administered administered 120 mins with sips of water before spinal anesthesia. 
Comparator Agent  Group 3 - Placebo  Preoperative oral placebo (Multivitamins tablet as it has same appearance as Midodrine tablet with no cardiovascular effect), administered administered 120 mins with sips of water before spinal anesthesia.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients aged 18-65 years
Patients scheduled for elective lower limb orthopedic surgery under spinal anesthesia
BMI 35kg per m2
American Society of Anesthesiologists ASA physical status I and II
Willingness to participate and provide written informed consent 
 
ExclusionCriteria 
Details  Contraindications to spinal anesthesia like coagulopathy and infection at the puncture site
Contraindications to midodrine like pheochromocytoma and severe heart disease
Patients with a history of significant cardiovascular disease like heart failure and uncontrolled hypertension
Patients with renal or hepatic impairment
Patients taking medications that may interact with midodrine like alpha-adrenergic agonists and MAO inhibitors
Pregnancy or lactation
Patients with a known allergy to midodrine
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Incidence of post spinal anesthesia hypotension defined as systolic blood pressure less than ninety mmHg or a decrease of mean arterial pressure more than twenty percent from baseline  After spinal anesthesia every 2 mins for initial 20 mins then every 5 mins till end of surgery 
 
Secondary Outcome  
Outcome  TimePoints 
Number of hypotensive episodes
Severity of hypotension after spinal anaesthesia like duration of hypotensive episodes and lowest systolic blood pressure or Mean Arterial Pressure
Total dose of rescue vasopressors required
Changes in hemodynamic parameters like systolic blood pressure diastolic blood pressure and heart rate from baseline
Incidence of bradycardia defined as heart rate less than 50 bpm
Incidence of adverse events like nausea vomiting headache and hypertension
 
Intraoperative and two hours post operative period 
 
Target Sample Size   Total Sample Size="126"
Sample Size from India="126" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   04/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Spinal anesthesia is a form of neuraxial block

Hypotension is the most common complication

Midodrine it is an alpha one agonist drug  which is  arteriolar and venous vasocontriction leads to increase in systolic blood pressure

Previous studies of oral midodrine for prevention of hypotension after spinal anesthesia  it has shown promising results

Different Studies was done with different dose of oral midodrine and placebo

In this study we wish to compare two doses of oral midodrine to known the effective dose in preventing hypotension after spinal anaesthesia with minimal side effects

It is randomized double blind study

 
Close